Revolutionizing Non-Invasive Diagnostics with Plasmion’s SICRIT Breath Analysis.
Optimi Health Granted Amendment to Dealer’s Licence by Health Canada to Supply Special Access Program – Psychedelic Alpha
VANCOUVER, British Columbia, Sept. 07, 2023 (GLOBE NEWSWIRE) — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a Canadian psychedelics drug research and formulation